[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343996-105":59,"doc-detail-343996-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","study-on-the-mechanism-of-liver-cancer-immune-escape-mediated-by-mindy1-through-regulation-of-pd-l1-ubiquitination-level","Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level","","Research investigates how MINDY1 mediates immune escape in liver cancer by regulating PD-L1 ubiquitination level. Expression of MINDY1 and PD-L1 was measured in tumor and adjacent tissues from 50 hepatocellular carcinoma patients, and correlations with 5-year tumor-free survival were analyzed. In Huh7 cells, MINDY1 was silenced with siRNA or overexpressed. Functional assays assessed proliferation, apoptosis, migration, invasion, and PD-L1 binding/ubiquitination, showing that higher MINDY1 or PD-L1 predicts worse survival. MINDY1 directly interacts with PD-L1, promoting or preventing its ubiquitination. Results indicate MINDY1 inhibits malignant progression by restraining PD-L1 ubiquitination and enabling immune escape.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/study-on-the-mechanism-of-liver-cancer-immune-escape-mediated-by-mindy1-through-regulation-of-pd-l1-ubiquitination-level/343996/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/study-on-the-mechanism-of-liver-cancer-immune-escape-mediated-by-mindy1-through-regulation-of-pd-l1-ubiquitination-level/343996.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main research question of the study?","Question",{"text":113,"@type":114},"How MINDY1 mediates immune escape in liver cancer through regulation of PD-L1 ubiquitination level.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were MINDY1 and PD-L1 levels assessed in patients?",{"text":118,"@type":114},"Expression in liver cancer and adjacent tissues from 50 hepatocellular carcinoma patients was examined using protein imprinting and immunohistochemistry.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does MINDY1 play in PD-L1 ubiquitination and immune escape?",{"text":122,"@type":114},"MINDY1 directly interacts with PD-L1; knocking down MINDY1 promotes PD-L1 ubiquitination, while MINDY1 overexpression inhibits PD-L1 ubiquitination, supporting a mechanism for immune escape and malignant progression control.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343996,1790163918,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","RESEARCH ARTICLE  \nStudy on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level  \nXingchao Song1, 2\\#, Wenjin Li2\\#, Chunyan Tian2, Xiao Ma2, Weibin Yang2, and JiaHua Zhou1 ∗  \nThe novel deubiquitinase enzyme, motif interacting with ubiquitin-containing novel DUB family-1 (MINDY1), is highly expressed in liver cancer tissues and plays a crucial role in maintaining the stemness of liver cancer cells. Programmed death ligand-1 (PD-L1) is an immunosuppressive molecule overexpressed by tumor cells. The potential role of MINDY1 in inhibiting the stemness of liver cancer cells by deubiquitinating PD-L1 has not yet been reported. To investigate the mechanism by which MINDY1 mediates immune escape in liver cancer through the regulation of PD-L1 ubiquitination, we examined the expression levels of MINDY1 and PD-L1 in liver cancer and adjacent tissues from 50 hepatocellular carcinoma (HCC) patients using protein imprinting and immunohistochemistry. We analyzed the relationship between the expression levels of MINDY1 and PD-L1 in liver cancer tissues and their correlation with the 5-year tumor-free survival rates of patients. Subsequently, MINDY1 expression was knocked down in Huh7 cells using small interfering RNA interference or upregulated through transfection with a MINDY1 overexpression plasmid. The effects of MINDY1 knockdown or overexpression on the proliferation, apoptosis, migration, and invasion of HCC cells, as well as the regulation of PD-L1 binding and ubiquitination, were assessed. The 5-year tumor-free survival rates were significantly lower in both the high MINDY1 expression group and the high PD-L1 expression group (χ2 = 4 .919 and 13 .158, respectively) . A significant difference in survival was observed between the high and low MINDY1 expression groups (χ2 = 27 .415) . MINDY1 was found to directly interact with PD-L1, with MINDY1 gene knockdown promoting PD-L1 ubiquitination and MINDY1 overexpression inhibiting PD-L1 ubiquitination. All comparisons yielded statistically significant results (P \u003C 0.05) . In conclusion, MINDY1 inhibits the malignant progression of liver cancer by inhibiting PD-L1 ubiquitination and mediating immune escape.  \nKeywords: Motif interacting with ubiquitin-containing novel DUB family-1 (MINDY1), programmed death ligand-1 (PD-L1), ubiquitination, hepatocellular carcinoma (HCC), immune escape, mechanism.  \nIntroduction  \nPrimary liver cancer is a highly prevalent and dangerous malignant tumor in China, with the ﬁfth-highest incidence and the second-highest mortality [1] . The major causes of primary liver cancer are hepatitis B, hepatitis C, and cirrhosis caused by alcohol, followed by aﬂatoxin, non-alcoholic fatty liver disease, and liver ﬂuke [2] . Hepatocellular carcinoma (HCC) is the most important type of primary liver cancer, accounting for 80% of total cases [3]. HCC has an insidious onset, strong invasion, anda tendency for easy metastasis and recurrence [4] . Treatment of this disease includes surgical resection, transhepatic arterial embolization chemotherapy, molecular targeted drug therapy, immunotherapy, etc., but the results are still unsatisfactory [5] . The progression of HCC in the body is a multi-step process, including occurrence, development, invasion, and metastasis, and involves many factors. At present, the understanding of  \nits molecular events in the medical community is incomplete. Exploring the mechanisms of invasion and metastasis of HCCand searching for molecular targets are still urgent problems tobe solved.  \nThe body’s innate immune system can monitor, recognize, and eliminate mutant tumor cells and inhibit their development. However, some tumor cells can evade attack and destruction by the immune system by changing antigen speciﬁcity, secreting inhibitory cytokines, or participating in negative immune regulation, etc., leading to immune escape [6, 7] . Programmed death ligand-1 (PD-L1) is an immunosuppre","cbCaihdeCCGUV9Sm","https://ap.wps.com/l/cbCaihdeCCGUV9Sm","pdf",2203539,"English","# Introduction\n## Immune escape and PD-L1 in liver cancer\n## MINDY1 as a regulator via PD-L1 ubiquitination\n# Methods and experimental design\n## Patient tissue analysis\n## Cell model manipulation of MINDY1\n## Functional and survival correlations\n# Results\n## Associations between MINDY1/PD-L1 and 5-year tumor-free survival\n## MINDY1 effects on HCC cell behaviors\n## MINDY1-PD-L1 interaction and ubiquitination regulation\n# Conclusion","[{\"question\":\"What is the main research question of the study?\",\"answer\":\"How MINDY1 mediates immune escape in liver cancer through regulation of PD-L1 ubiquitination level.\"},{\"question\":\"How were MINDY1 and PD-L1 levels assessed in patients?\",\"answer\":\"Expression in liver cancer and adjacent tissues from 50 hepatocellular carcinoma patients was examined using protein imprinting and immunohistochemistry.\"},{\"question\":\"What role does MINDY1 play in PD-L1 ubiquitination and immune escape?\",\"answer\":\"MINDY1 directly interacts with PD-L1; knocking down MINDY1 promotes PD-L1 ubiquitination, while MINDY1 overexpression inhibits PD-L1 ubiquitination, supporting a mechanism for immune escape and malignant progression control.\"}]","Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level | PDF",1790052727,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ec4c02962aeda5f7a1c641ec95a73f8.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91abef98dbcf43adcc525fb06ac8cf14.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4287e99c8e506a76b5885d047f75537d.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ed30ae5a689a063bb5fdabe61658844.webp",980,1268]